Indonesia

Challenge TB | Lead Partner: KNCV | Country Director: Erik Post

Our Activities

Indonesia is both a high-burden TB and high HIV burden country with the fastest growing HIV epidemic in the region.

Despite this the country is committed to bringing these twin epidemics under control. In 2017, Indonesian district majors in the presence of their Minister of Health, Nila Moeloek and their Minister of Home Affairs, Tjahjo Kumolo, signaled their commitment to accelerate tuberculosis efforts during the meeting “Acceleration towards Indonesia Free of TB: Multisectoral Contribution.” These signatures and the plan attached to them are Indonesia’s response to the WHO Global Ministerial Conference in Moscow that took place in November 2017.

Challenge TB in Indonesia is a 5 year USAID funded project supporting the National TB Program with implementation of the national strategic plan for TB through ensuring technical leadership. The project helps the NTP in making strategic choices for a sustainable difference, ensuring the highest impact with limited resources. Challenge TB Indonesia is led by KNCV, collaborating with two in-country coalition partners FHI 360 and WHO. KNCV is assisted through short-term technical assistance from three external coalition partners; American Thoracic Society (ATS), Management Sciences for Health (MSH) and Interactive Research and Development (IRD). The overall aim of the project is to implement a broad range of (distinct financial and technical) sustainable interventions.

Challenge TB works in nine provinces: Five of these provinces (Jakarta, West Java, Central Java, East Java, and North Sumatra) are prioritized and receive intensified assistance in 10 priority districts, supporting down to selected (sub) district level. The aim is to design “best models”, testing these through small-scale implementation at district level, with a view to scaling up these best models both within these provinces and more broadly. The intensified package includes all components of TB control including laboratory network strengthening, PPM, PMDT, TB/HIV and surveillance.

Additionally Challenge TB provides technical support to 4 other provinces (Papua, West Papua, West Sumatra and South Sulawesi). The focus in these provinces are on expansion and quality assurance of essential components of TB control including laboratory, TB/HIV, PMDT expansion and intensified TB case finding. Local health services and partners in these provinces will receive a more ‘’specified package’’ of technical assistance based on their needs.

Challenge TB Indonesia will also provide support to the principal recipients of Global Fund TB. As a Sub Recipient, KNCV will assist the recipients to address specific technical and managerial issues, and support in planning, implementation and troubleshooting. USAID/Challenge TB Support is complementary to Global Fund assistance.

Our Office

KNCV Tuberculosis Foundation in Indonesia

Gedung Menara Bidakara 2, Lt.7

Jl. Jend. Gatot Subroto Kav. 71-73

Pancoran – Jakarta Selatan 12870, Indonesia

KNCV has been fighting TB since its establishment in 1903. Over the past 117 years, the organization has acquired indispensable knowledge and experience in the field of effective TB control, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

Annual Report Summary 2019
KNCV 2-pager ASCENT
KNCV 2-pager Childhood TB
KNCV 2-pager Digital Health
KNCV 2-pager General
KNCV 2pager Right Diagnosis, Right Treatment
KNCV 2-pager TB Photovoices
KNCV 2-pager TB Stigma

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.